Pages:
Author

Topic: [ANN][ICO] BioNT - Advanced Pharma Intelligence - 20% Bonus first 2 weeks - page 2. (Read 2336 times)

full member
Activity: 280
Merit: 100
is there a possibility to use the working beta or is its just for companies? Will the product have any use in the academic field of Pharmacy Study. Thanks

Good Luck
newbie
Activity: 10
Merit: 0
Dear Bitcoinforum members
 
We opted for a soft launch to ensure security, with less of a focus on "hype and marketing"

The current token contribution is not spectacular, however we want to assure you that we are gonna keep our promises.

We have a working beta product and first clients are already on boarded.

Herewith, we want to guarantee you, that 50% of our revenue will be used to buy back tokens on exchanges. So if you have contributed already, you can rest assure your investment is safe and you will get the portion of the revenue when we buy back the tokens.

With only few token holders so far, you will get most probably a very nice ROI Smiley
 
We are thinking to launch a second round of token sale as well, better prepared, with better marketing campaign, so watch this space.
 
Cheers
newbie
Activity: 6
Merit: 0
A network of colleagues, they form our client base
member
Activity: 69
Merit: 10
"@Dev ..you guys from Crypto Valley Zug or just a post box here ? Asking this for the 3rd time now"

YES WE ARE ZUG BASED in the heart of Switzerland.

Core team members based in Zug from 10 to 15 years. 

This the EU hub for Biotech and Pharma, hence the main reason why we are here.  Please review the white papers for our full details.

also review the video - it highlights the core 20 biotechs that are based here.
J&J, Biogen, Amgen, Roche, Novartis, Takeda, Shire, Baxter, these are just a few...many more.

Thanks BioNT
Do you have partnership with any of these companies?
sr. member
Activity: 378
Merit: 252
The Dutch announcement thread is now online:
https://bitcointalksearch.org/topic/annico-biont-advanced-pharma-intelligence-eerste-twee-weken-20-bonus-2196060

The Dutch Telegram channel can be found here:
https://t.me/biont_nl

The Dutch whitepaper can be downloaded here:
https://uploadfiles.io/vmykp
newbie
Activity: 41
Merit: 0
Any plans for a roadshow or presentations in Switzerland??
newbie
Activity: 10
Merit: 0
<<<<<<<<<< '5% bonus week has started >>>>>>>>>>>>>>>>>>

newbie
Activity: 84
Merit: 0
To give real service, you must add something which cannot be bought or measured with money, and that is sincerity and integrity.
newbie
Activity: 6
Merit: 0
"@Dev ..you guys from Crypto Valley Zug or just a post box here ? Asking this for the 3rd time now"

YES WE ARE ZUG BASED in the heart of Switzerland.

Core team members based in Zug from 10 to 15 years. 

This the EU hub for Biotech and Pharma, hence the main reason why we are here.  Please review the white papers for our full details.

also review the video - it highlights the core 20 biotechs that are based here.
J&J, Biogen, Amgen, Roche, Novartis, Takeda, Shire, Baxter, these are just a few...many more.

Thanks BioNT
newbie
Activity: 59
Merit: 0
This looks very good. Good luck Cheesy
newbie
Activity: 41
Merit: 0
@Dev ..you guys from Crypto Valley Zug or just a post box here ? Asking this for the 3rd time now
newbie
Activity: 6
Merit: 0
"Is there a minimum amount you need to gather in investments in order for the project to start?"

We did not set a minimum, as our private investors will also come through in the October, they - we are awaiting FINMA approval based on a KPMG audit.
This will be the 1st ICO with a Swiss Prospectus, expected early next week.

The project has 3 phases, dependent upon how which raise will drive the speed of development, 1st the pricing system (push the beta into commercial), 2nd the drug forecasting platform (beta to production, and then commercial) and finally the 3rd decentralised trading platform - this will be a significant phase of the project to provide trading signals for traders and investors around the world. 
legendary
Activity: 1680
Merit: 1010
Professional Native Greek Translator (2000+ done)
Is there a minimum amount you need to gather in investments in order for the project to start?
newbie
Activity: 41
Merit: 0
ADP guys or BIONT guys are you planning any local road shows or presentations? In Switzerland at least in Zug or Zurich?
newbie
Activity: 6
Merit: 0
" I will follow your campaign. but I want to ask. How will you convince pharmaceutical companies to use this technology? I understand the part about the pricing of medicines. and there are many domestic companies besides international companies. Which country is your first destination? I think I'm a little confused."

We already have beta a version of the pricing system, we don't need to convince pharma companies to use the system, they need the system due to the changing complexity of government price reporting, US and EU which is mandatory.  The target base for user's is Swiss based Biotech (in Zug-Zurich) & US based (Boston-Bay). Hope this helps?  
member
Activity: 65
Merit: 10
140,000,000 TOKENS, 300 BioNT per ETH => total 466.666 ETH... wow, great ICO
full member
Activity: 126
Merit: 100
I will follow your campaign. but I want to ask. How will you convince pharmaceutical companies to use this technology? I understand the part about the pricing of medicines. and there are many domestic companies besides international companies. Which country is your first destination? I think I'm a little confused.
full member
Activity: 364
Merit: 101
Bookmarked for closer inspection.
newbie
Activity: 41
Merit: 0
Are these guys really from Crypto Valley? If so great as would be great to meet/see them face to face !!!

Any roadshows or any events planned locally?
Also have been watching the ICO space for a while and saw only this one which targets Pharma & Biotech. As I see it this project was not promoted earlier wondering why?
newbie
Activity: 6
Merit: 0
And you are right - the reference source is 2022 for $1.2Tr global revenue. Thank you.

The market cap of the top 100 pharma companies is already $2.2Tr as stated.

Btw, we do not work for large pharma, lets make this clear...

We only work for small starts up Biotech's, Orphan Diseases, and Oncology (chimeric immunoreceptors, T cell receptors, artificial T cell receptors or CAR-T)

This is a specialist area, but incredibly risky and volatile, we try and avoid big pharma.

These small Biotechs  ($100m - $5Bn, this is small in pharma world), they will benefit from our specialist solutions - it will allow them to secure funding to develop life saving molecules - they are not thinking about Porches or Yachts, ONLY PATIENTS!   

This is detailed in the white paper, thank you for questions and support.

Btw, we are based in Zug Switzerland, the team members have been here between 10-15 years. This has been my family home for the past 15 years.
Pages:
Jump to: